Glossary · EU medical devices: MDR
Clinical evaluation (MDR)
Also known as: MDR clinical evaluation, Clinical evaluation report (CER)
Under the EU Medical Device Regulation (EU) 2017/745, clinical evaluation is the systematic and planned process to continuously generate, collect, analyze and assess the clinical data on a device in order to verify its safety and performance, including its clinical benefits, when used as intended. It is required for every device class, follows Article 61 and Annex XIV Part A and is documented in a clinical evaluation report.
- EU
- MDR
- Technical documentation
In one sentence
Clinical evaluation under MDR Article 61 and Annex XIV: the planned, continuous assessment of clinical data on a device’s safety and performance.
Example
A manufacturer of a class IIb bone screw writes a clinical evaluation plan, appraises published studies and its own PMCF data, and concludes in the clinical evaluation report that the benefit-risk ratio is acceptable for the stated indications.
Explained in context
This term is a station of a mini course
- The medical-device evidence chain: from intended purpose to post-market evidenceStation: Clinical and performance evidenceStart the course
Context cards connect this term with others to answer one question. Also in British English and German.
- Claims are controlled information objects: from claim to evidence in a medical device fileHow should claims about a medical device be managed so that each one is backed by evidence?UKDeutsch
- The intended purpose as the semantic anchor of the technical fileWhy is the intended purpose the reference point of every document in a medical-device technical file?UKDeutsch
- A medical-device technical file is not a collection of documents. It is an evidence system.What makes a medical-device technical file an evidence system rather than a set of documents?UKDeutsch
- Clinical evidence owner: a functional roleWho keeps the clinical and performance evidence of a device in step with the IFU, the claims and the post-market data?UKDeutsch
- The medical-device evidence chain: from intended purpose to post-market evidenceHow do the parts of a medical device’s technical documentation connect — and what has to be in place before an AI function may answer from it?UKDeutsch
- Training data provenance is part of the device file, not a data-science recordWhy does the origin of training data belong in the technical documentation of an AI-enabled medical device?UKDeutsch
How it applies
- Plan first: The evaluation starts from a clinical evaluation plan that names the relevant general safety and performance requirements, the intended purpose, target groups, clinical benefits and the parameters used to judge the benefit-risk ratio against the state of the art.
- Data sources: Clinical data can come from clinical investigations of the device, from published literature on the device or an equivalent device, and from post-market clinical follow-up. Each source is appraised for relevance and quality.
- Equivalence: Claiming equivalence to another device requires showing technical, biological and clinical equivalence and, under the MDR, sufficient access to the data of that device. MDCG 2020-5 explains the expectations.
- Class III and implantable devices: As a rule these need clinical investigations of the device itself; Article 61 lists the exceptions. MDCG 2020-6 covers sufficient clinical evidence for legacy devices.
- Lifecycle: The evaluation is not a one-off. It is updated with post-market surveillance and PMCF data throughout the life of the device.
- Technical documentation: The clinical evaluation report is part of the technical documentation under Annex II and is reviewed by the notified body for devices above class I. For implantable and class III devices it feeds the SSCP.
Clinical evaluation vs. clinical investigation
Clinical evaluation is the overall assessment of all available clinical data, done for every device. A clinical investigation is one way to generate such data: a study in human subjects under Articles 62 to 82 and Annex XV. Many lower-risk devices are evaluated without a new investigation; the evaluation always exists. For IVDs the counterpart is the performance evaluation under the IVDR.